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Abstract
Resistance exercise and whey protein supplementation are effective strategies
to activate muscle cell anabolic signaling and ultimately promote increases in
muscle mass and strength. In the current study, 46 healthy older men aged
60–75 (69.0  0.55 years, 85.9  1.8 kg, 176.8  1.0 cm) performed a single
bout of unaccustomed lower body resistance exercise immediately followed by
ingestion of a noncaloric placebo beverage or supplement containing 10, 20,
30, or 40 g of whey protein concentrate (WPC). Intramuscular amino acid
levels in muscle biopsy samples were measured by Gas Chromatography–Mass
Spectrometry (GC-MS) at baseline (before exercise and WPC supplementa-
tion) plus at 2 h and 4 h post exercise. Additionally, the extent of p70S6K
phosphorylation at Thr389 in muscle biopsy homogenates was assessed by
western blot. Resistance exercise alone reduced intramuscular branch chain
amino acid (BCAA; leucine, isoleucine, and valine) content. Supplementation
with increasing doses of whey protein prevented this fall in muscle BCAAs
during postexercise recovery and larger doses (30 g and 40 g) significantly
augmented postexercise muscle BCAA content above that observed following
placebo ingestion. Additionally, the fold change in the phosphorylation of
p70S6K (Thr389) at 2 h post exercise was correlated with the dose of whey
protein consumed (r = 0.51, P < 001) and was found to be significantly corre-
lated with intramuscular leucine content (r = 0.32, P = 0.026). Intramuscular
BCAAs, and leucine in particular, appear to be important regulators of ana-
bolic signaling in aged human muscle during postexercise recovery via reversal
of exercise-induced declines in intramuscular BCAAs.
Introduction
Skeletal muscle mass is tightly regulated by the balance
between rates of muscle protein synthesis (MPS) and
muscle protein breakdown (MPB). Increases in MPS
induced by both resistance exercise and protein feeding
are thought to be mediated primarily though the mam-
malian target of rapamycin (mTOR) pathway. p70S6
kinase (p70S6K) is a major downstream component of
the mTOR pathway which is responsible for the initiation
of protein translation and is thus often used as a proxy
measure for MPS (Drummond et al. 2009). Amino acids
(AAs), and leucine in particular, have been proposed to
be the primary nutritional regulators of the mTOR signal-
ing pathway cumulating in increases in MPS (Smith et al.
1992; Atherton et al. 2010). MPS appears to be much
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more tightly regulated when compared to MPB, and for
this reason, MPS and associated anabolic signaling often
serve as the primary measures in relation to the influence
of protein feeding and resistance exercise on muscle pro-
tein turnover (Glynn et al. 2010). In many cases, acute
p70S6K phosphorylation correlates with long-term
changes in muscle size (Baar and Esser 1999; Terzis et al.
2008; Mayhew et al. 2009; Mitchell et al. 2013). However,
there are also reports of a lack of correlation between
acute MPS or p70S6K and hypertrophy responses within
the same subject, suggesting that additional mechanisms
may be involved (Mitchell et al. 2012, 2014). Neverthe-
less, multiple studies which have tested the acute (MPS
and p70S6K phosphorylation) and chronic (hypertrophic)
effects of the same exercise or nutritional manipulation in
different subjects do tend to show very similar patterns of
group changes (Hartman et al. 2007; Wilkinson et al.
2007; West et al. 2009a,b; Burd et al. 2010a,b; Mitchell
et al. 2012, 2013).
The ingestion of graded amounts of high-quality protein
such as whey after resistance exercise has been shown to
increase MPS in a dose-dependent manner. In young men
(20–30 years), there appears to be a ceiling above which
no further augmentation of MPS occurs in response to
protein ingestion. For example, a plateau in MPS occurs
following ingestion of 20 g of either egg (Moore et al.
2009) or whey (Witard et al. 2014) protein in young male
subjects, with no greater MPS response observed in
response to surplus ingestion of 40 g protein. However,
multiple studies have shown that older adults (>60 years)
exhibit a lower anabolic signaling and MPS response to
protein feeding, resistance exercise, and the combination
of feeding and exercise when compared to young men
(Cuthbertson et al. 2005; Fry et al. 2011; Burd et al. 2013).
This phenomenon termed “anabolic resistance” is exempli-
fied by a recent study by Yang et al. (2012b) which showed
that MPS in older men following resistance exercise
increased to a greater extent after the ingestion of 40 g of
whey protein when compared to the response elicited by
20 g whey protein (Yang et al. 2012b). Nevertheless, the
magnitude of the MPS response to feeding 40 g of protein
was slightly less in older men than that which was
observed in young men who were fed a maximally effective
20 g dose of protein (Yang et al. 2012a; Churchward-
Venne et al. 2013b). It appears that deficits in feeding-
induced p70S6K phosphorylation may at least partially
underpin anabolic resistance in aged skeletal muscle (Cut-
hbertson et al. 2005). Much less is known about the effect
of graded whey protein ingestion on p70S6K phosphoryla-
tion in older human subjects, which is the putative mecha-
nism underlying nutrient-induced increase in MPS.
It is well established that ingestion of amino acids (AA)
or intact protein leads to dose-dependent increases in
circulating plasma essential amino acids (EAAs; Bohe et al.
2003; Moore et al. 2009; Yang et al. 2012b; Witard et al.
2014). On the other hand, much less is known about the
effect of resistance exercise and protein feeding on the
concentrations of AAs within the muscle tissue itself. A
classic study by Bohe et al. showed a stronger relationship
between plasma EAAs and MPS when compared to intra-
muscular EAA concentrations (Bohe et al. 2003). How-
ever, the concentrations of the individual EAAs were not
reported independently in this study (Bohe et al. 2003).
The authors hypothesized that MPS was primarily regu-
lated by extracellular rather than intracellular EAA avail-
ability. However, it has since been demonstrated that
among the EAAs, leucine one of the three Branched-Chain
Amino Acids (BCAAs), appears to be the primary trigger
of amino acid-induced anabolic signaling and MPS (Ath-
erton et al. 2010). Moreover, recent mechanistic work sug-
gests that the activation of mTOR in response to leucine is
sensed through intracellular proteins such as the leucyl-
tRNA synthetase (Han et al. 2012) and/or the ragulator
(Zoncu et al. 2011). Consistently, recent work has also
suggested that the pattern of change in BCAAs in response
to resistance exercise and protein feeding may be different
when compared with the other EAAs (Drummond et al.
2010, 2011; Churchward-Venne et al. 2012, 2014).
The purpose of the present study was to characterize
the changes in intramuscular levels of EAAs and BCAAs
in response to resistance exercise and graded ingestion of
whey protein in older men. A secondary aim was to
determine the effects of graded intakes of whey protein
on the extent of exercise-induced phosphorylation of
p70S6K at Thr389 as a marker of mTOR pathway activa-
tion in the muscle of older men and to examine the rela-
tionship between intramuscular EAA/branch chain amino
acid (BCAA) levels and growth signal transduction via the
mTOR pathway.
Methods
Subjects and ethical approval
Forty six healthy elderly untrained men (60–75 years of
age) volunteered to participate in this study, subject char-
acteristics are reported in Table 1. Individuals participating
in any regular resistance exercise training program (two or
more days per week) and/or with preexisting metabolic or
cardiovascular diseases were excluded. Individuals who
engaged in aerobic exercise up to three times per week and/
or were taking anticoagulation or antihypertensive medica-
tion were not excluded from participation, however, those
on aspirin/fish oil supplements were requested to abstain
from these medications throughout the experimental trial.
Prior to any experimental procedures, subjects were
2014 | Vol. 2 | Iss. 8 | e12112
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provided with oral and written information regarding the
experimental protocols and potential risks involved and
written consent to participate was obtained. Randomiza-
tion to place immediately after consent was obtained. All
experimental procedures employed by this study were car-
ried out in coherence with the Helsinki declaration and
were formally approved by the Deakin University Human
Research Ethics Committee.
Study design
Approximately 1 week prior to the experimental trial day,
participants performed a familiarization session during
which one-repetition maximum (1RM) strength testing
was also performed to determine the experimental exer-
cise load (80% of 1RM). The maximal weight that sub-
jects could lift for 3–6 repetitions (3–6 RM) on the
bilateral barbell squat, leg press, and leg extension exer-
cises was determined and participants 1RM was estimated
using the Brzycki equation (1RM = 100 9 load rep/
(102.78–2.78 9 reps completed; Reynolds et al. 2006).
Participants were instructed to abstain from any vigorous
physical activity in the week between the familiarization
and the experimental trial day. The evening before the
trial, participants ingested a standard evening meal
(2103 kJ, 54% carbohydrate, 29% fat, 17% protein)
before 10 pm and were instructed to eat nothing after-
ward. The following morning, the subjects arrived at
(~7 am) in a fasted state. Participants were randomly
allocated into one of five treatment groups; noncaloric
placebo (n = 15), 10 g whey (n = 7), 20 g whey (n = 7),
30 g whey (n = 7), and 40 g whey (n = 10).
Resistance exercise and supplementation
trial
Upon arrival at the laboratory, individuals rested in a
supine position for ~30 min prior to collection of resting
muscle biopsy samples (see below section). Participants
then rested supine following collection of resting muscle
biopsy for approximately 10–15 min after which time the
exercise protocol commenced. The exercise protocol began
with a 10-min warm-up involving light cycling on a bicy-
cle ergometer and a single low load warm-up set for each
of the three resistance exercises. Participants then com-
pleted three sets of 8–10 repetitions of bilateral barbell
smith rack squat, 45° leg press, and seated knee extensions
at 80% of their predetermined 1RM. The exercises were
performed in a circuit manner with 1 min rest between
each exercise and 3 min rest between subsequent sets, the
exercise protocol took approximately 20 min to complete.
Following completion of the exercise protocol, subjects
were immediately provided with a fixed-volume (350 mL)
beverage, containing a flavored noncaloric placebo, or one
of the four doses of whey protein concentrate (10 g, 20 g,
30 g, or 40 g). Subjects were instructed to ingest the bev-
erage within 2 min and were required to ingest the total
volume provided. Following consumption of the supple-
ments, subjects rested in a supine position throughout the
4 h of postexercise recovery with additional muscle biopsy
samples collected at 2 and 4 h post exercise.
Muscle biopsies
Muscle biopsies (~100 mg) were collected from the vastus
lateralis muscle under local anesthesia (1% Xylocaine)
using a Bergstrom needle modification of manual suction.
All three biopsies were collected from the same limb
starting distally and moving proximally. A gap of at least
2–3 cm between sequential biopsies was maintained in
order to avoid any potential confounding effects caused
by repeated sampling for the same location. Biopsies were
quickly frozen in liquid nitrogen and stored at 80°C
until further analyses.
Western blotting
Muscle tissue (~50 mg) was homogenized in ice-cold
RIPA lysis buffer (50 mmol/L Tris-HCl, pH 7.4,
150 mmol/L NaCl, 0.25% deoxycholic acid, 1% NP-40,
Table 1. Subject characteristics. Means  SD.
Placebo 10 g Whey 20 g Whey 30 g Whey 40 g Whey
n 15 7 7 7 10
Age (years) 67.8  3.9 71.1  4.9 69.3  3.6 70.0  3.3 68.1  4.1
Body mass (kg) 89.6  14.0 82.8  8.3 90.5  19.5 79.6  9.0 84.7  11.8
Height (m) 1.80  0.04 1.74  0.04 1.78  0.10 1.72  0.06 1.78  0.10
BMI (kg/m2) 27.5  4.6 27.4  3.3 28.6  5.4 27.4  3.0 26.5  3.3
1-RM Squat (kg) 84.1  33.0 59.6  11.3 81.0  26.9 67.9  19.6 90.8  39.9
1-RM Leg press (kg) 177.7  73.5 175.9  28.2 211.9  111.6 183.4  32.9 205.4  66.4
1-RM Leg Ext. (kg) 53.01  21.9 52.6  10.6 49.9  29.9 56.0  10.2 68.7  21.1
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1 mmol/L EDTA supplemented with a cocktail of prote-
ase and phosphatase inhibitors including 1 mmol/L
PMSF, 1 lg/mL aprotinin, 1 lg/mL leupeptin, 1 mmol/L
Na3VO4, and 1 mmol/L NaF). The resulting homogenates
were agitated for 1 h at 4°C, centrifuged for 15 min at
13,000 g, and the protein content of the supernatant was
determined using a BCA-protein assay kit (Pierce, Rock-
ford, IL) following the manufacturer’s instructions. Aliqu-
ots of protein homogenate containing 50 lg of total
protein were prepared, mixed with Laemmli buffer,
boiled, and subjected to SDS/PAGE. Proteins were sepa-
rated on an 8% gel and wet-transferred to a polyvinyl
difluoride (PVDF) membrane. Following transfer, mem-
branes were blocked in 5% bovine serum albumin (BSA)/
Tris Buffer Saline/0.1% Tween 20 (TBST) for 1 h, fol-
lowed by overnight incubation at 4°C with primary anti-
body against p-p70S6K (Thr389; 1:1000, Cell Signalling,
Danvers, MA). The following morning, membranes were
washed for 30 min with TBST and probed with a goat
anti-rabbit IgG conjugated to horseradish peroxidase
(HRP) secondary antibody (1:2000) for 1 h at room tem-
perature. Membranes were then washed for 30 min in
TBST and protein bands were visualized using Western
Lighting-enhanced chemiluminescence reagent (Perkin-
Elmer Life Sciences, Boston, MA). Signals were captured
using a Kodak Digital Science Image Station 440CF (East-
man Kodak Company, Rochester, NY), and densitometry
band analysis undertaken with Kodak Molecular Imaging
Software (Version 4.0.5; Eastman Kodak Company).
Phospho-p70S6K (Thr389) probed membranes were
stripped and reprobed for Total p70S6K (1:1000, Cell Sig-
nalling) using Restore Western Blot Stripping Buffer
(Pierce). Due to large changes observed in the electropho-
retic mobility of the Total p70S6K protein in highly phos-
phorylated postexercise and supplementation muscle
samples it was difficult to accurately quantify total
p70S6K. This large magnitude mobility shift in total
p70S6K in samples with large degrees of p70S6K phos-
phorylation has been previously described (Karlsson et al.
2004). Total ERK2 (ERK1/2 Cell Signalling, 1:1000) was
thus used as a loading control because it did not change
in any condition. Loading normalized western blot data
was calculated as fold change against subjects respective
baseline sample which was always ran in contiguous lanes
on the same gel.
Metabolomics
Muscle tissue (~50 mg) was homogenized in 500 lL of
ice-cold 50% methanol spiked with 20 lL of 10 mmol/L
D-4 Alanine (as an internal standard) using 2.8 mm cera-
mic beads and a bead mill homogenizer (OMNI RUP-
TOR 24, 5.65 m/sec, 30 sec). The muscle homogenate
was transferred to a new tube, vortexed vigorously for
1 min, and frozen rapidly on dry ice. This process was
repeated through two more freeze–thaw cycles. Samples
were then centrifuged at 3000 g for 10 min, the superna-
tant was collected in a 15 mL falcon tube and placed on
dry ice. The remaining tissue pellets were resuspended in
500 lL of 80% methanol and vigorously vortexed for a
further 1 min. The suspension was centrifuged at 8000 g
for 10 min and the resulting supernatant was pooled with
that from the first centrifugation and the remaining pellet
was discarded. The volume of the pooled supernatant was
increased to ~5–6 mL using milli-Q water, thoroughly
mixed, and were frozen at 80°C. Frozen samples were
evaporated to dryness overnight using an SC250 Express
SpeedVac Concentrator and RVT4104 Refrigerated Vapor
Trap (Thermo Scientific Savant, San Jose, CA). Dried
sample extracts were stored at 80°C until subsequent
derivatization in preparation for GC-MS analysis.
Methyl chloroformate (MCF) derivatization
Methyl chloroformate derivatization was based on the
previously optimized protocol (Smart et al. 2010). Freeze-
dried samples were resuspended in 200 lL of 1 mol/L
NaOH. Resuspended samples were transferred to silanized
reaction tubes to which 167 lL of methanol and 34 lL of
pyridine and 20 lL of MCF were then added. Samples
were vortexed for exactly 30 sec, and this process was
repeated once. To separate the MCF derivatives from the
reactive mixture, 400 lL of chloroform was added to the
mixture and vortexted for 10 sec. Thereafter, 400 lL of
50 mmol/L NaHCO3 was added and vortexed for 10 sec.
The upper aqueous phase was removed with a glass Pas-
teur pipette and 100 mg of anhydrous Na2SO4 was added
to dry the organic solution. Once dried, the remaining
chloroform solution was transferred to a Gas Chromatog-
raphy–Mass Spectrometry (GC-MS) vial.
GC-MS analysis and metabolites
identification
Gas Chromatography–Mass Spectrometry (GC-MS)
instrument parameters were based on those reported by
[Smart et al. (2010)]. The instrument used was an Agilent
7890A gas chromatograph coupled to an MSD-5975C
inert mass spectrometer with a split/splitless inlet. Using a
CTC PAL autosampler, 1 lL of sample was injected into
a glass split/splitless 4 mm ID straight inlet liner packed
with deactivated glass wool (Supelco). The inlet was set
to 290°C, pulsed splitless at 180 kPa for 1 min, pressure
of 56.76 kPa, and column flow of 1.0 mL/min, which
gave a calculated average initial linear velocity of 35 cm/
sec. 1.1 min after injection, the purge flow was set
2014 | Vol. 2 | Iss. 8 | e12112
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to 25 mL/min. The capillary column used was ZB1701
(Zebron, Phenomenex, North Shore City, New Zealand)
with 30 m 9 250 lm 9 0.15 lm film thickness. (86%
dimethylpolysiloxane, 14% cyanopropylphenyl, Phenome-
nex). Carrier gas was ultra-high-purity grade helium
(99.9999%, BOC). GC oven temperature programing
started isothermally at 45°C for 2 min, increased 9°C/min
to 180°C, held 5 min; increased 40°C/min to 220°C, held
5 min; increased 40°C/min to 240°C, held 11.5 min;
increased 40°C/min to 280°C, and held 2 min. The trans-
fer line to the MSD was maintained at 250°C, the source
at 230°C and quadropole at 150°C. 5.5 min into the run,
the detector was turned on and ran in positive-ion, elec-
tron-impact ionization mode, at 70 eV electron energy,
with electron multiplier set with no additional voltage rel-
ative to the autotune value. To monitor instrument carry-
over, N-hexane blanks were run for every 10–12 samples.
Identification of compounds was carried out using mass
spectra acquired in scan mode from 38 to 550 amu, with
detection threshold of 100 ion counts (Smart et al. 2010).
The raw values from the GC-MS were corrected to the
spiked internal standard (D-4 Alanine) and the wet mass
of the tissue samples. Values are expressed as a fold
change from the rested and fasted values because internal
standards of each amino acid were not used and it was
not possible to calculate absolute concentrations of AAs.
Data analysis
Data are presented as mean  standard error of the mean
(SEM). Outliers were removed using automated stringent
outlier testing (ROUTs 0.1%) in GraphPad Prism6 soft-
ware (GraphPad Software, Inc., La Jolla, CA) (Motulsky
and Brown 2006). Cleaned data were analyzed using a
two-way analyses of variance (ANOVA; treat-
ment 9 time) with repeated measures over time. Follow-
ing significant main or interaction effects, Holm–Sidak
post hoc tests were used for pairwise comparison between
time points and supplement groups. In addition to quan-
titative statistical analysis, a heat map of the data showing
percentage change in various amino acids from fasting
levels was generated using the R program gplots package
(heatmap.2 function) to identify patterns of relative
changes in amino acids over time in each supplementa-
tion group. Pearson product moment coefficients were
calculated to assess the relationships between variables; a
linear regression was used to determine the relationship
between whey protein dose and P70S6k phosphorylation.
ANOVAs and correlations were calculated using Sigma-
plot 12.5 (Systat Software Inc., San Jose, CA) Statistical
significance was set at P < 0.05 level.
Results
Intramuscular amino acids
Figure 1 displays a heat map of the changes in intramus-
cular amino acids in response to resistance exercise and
whey protein ingestion which we were able to resolve by
GC-MS. Significant changes in the EAAs were limited to
histidine and the three BCAAs; leucine, isoleucine and
valine. Intramuscular leucine decreased below fasting lev-
els at 4 h post exercise in the placebo group (P < 0.05),
with a strong trend toward a decrease at the 2 h time
Figure 1. Intramuscular amino acids. This figure is a heat map which shows groups means fold changes from the resting fasted condition.
Green represents a decrease in amino acid content, white represents no change, and red represents an increase in amino acid content.
*significant effect revealed by ANOVA P < 0.05. Specific pairwise differences are omitted for clarity but are reported in the results section.
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point (P = 0.06) as well (Fig. 2A). The significant drop in
muscle leucine during postexercise recovery was not
observed in the protein supplemented groups, and leucine
levels were elevated intramuscularly in the 30 g and 40 g
protein supplemented groups when compared to the pla-
cebo group at 2 h post exercise (P < 0.05), as well as for
the 40 g group only at 4 h post exercise (P < 0.001).
Similarly, intramuscular isoleucine levels (Fig. 2B) were
elevated in the 40 g whey group compared to the placebo
group at 4 h post exercise (P < 0.001), with similar trend
observed for the 30 g whey condition (P = 0.06). In the
placebo group, there was a drop in intramuscular valine
below fasting levels at both 2 and 4 h post exercise
(Fig. 2C). The decline in intramuscular valine during
postexercise recovery was reversed by graded protein
intake and achieved levels greater than the placebo group
at the 4 h post exercise time point for those receiving in
the 40 g whey supplementation group (P < 0.001).
Small but significant changes were observed for the
NEAAs ornithine, alanine, and proline. There was signifi-
cant main effect (P = 0.024) for greater ornithine concen-
trations at 4 h after exercise compared with 2 h. Elevated
proline intramuscular levels were observed within the
40 g whey group at 4 h compared to 2 h post exercise
(P = 0.002). Similarly, proline showed significantly greater
levels in the 40 g whey group compared to the placebo at
the 4 h post exercise time point (P = 0.006). At 4 h post
exercise, intramuscular alanine levels were greater in the
20 g whey group compared with the placebo (P = 0.003)
or the 10 g whey (P = 0.014) groups. At 4 h post exer-
cise, intramuscular alanine levels were greater in the 20 g
whey group compared with the placebo (P = 0.003) or
the 10 g whey (P = 0.014) groups There was also a
decrease in intramuscular glutamic acid at 2 h
(P < 0.001) post exercise regardless of the supplement
condition (Fig. 3A). Similarly, resistance exercise alone
induced a decrease in intramuscular aspartic acid at both
2 and 4 h post exercise (P < 0.001) in all the supplement
conditions (Fig. 3B). 4-Methyl-2-oxopentanoic acid (or
a-ketoisocaproic acid, a-KIC) was unchanged with the
exception of lower intramuscular levels at 2 h post exer-
cise in the 10 g whey group only (data not shown). The
heat map (Fig. 1) also shows that the mean concentra-
tions of some AAs did also tend to increase in whey sup-
plemented groups during postexercise recovery as
indicated by a red color, however, if not noted above
these changes did not achieve statistical significance
(P > 0.05).
Strong correlations were observed among intramuscular
levels of the BCAAs in response to resistance exercise and
whey protein supplementation. At the 2 h postexercise
time point, significant linear correlations were observed
between intramuscular leucine and isoleucine (r = 0.98,
P < 0.0001) leucine and valine (r = 0.95, P < 0.0001),
and between isoleucine and valine (r = 0.93, P < 0.0001).
These correlations indicate that the BCAAs display similar
kinetics and are metabolized in a similar manner.
p70S6K Thr389 phosphorylation
Figure 4 displays the fold change in p70S6K Thr389 phos-
phorylation during postexercise recovery in response to
graded intakes of whey protein. There was a significant
A
B
C
Figure 2. Intramuscular branch chain amino acids. Fold changes in
(A) leucine, (B) isoleucine, and (C) valine at rest, 2 h, and 4 h post
resistance exercise. *significantly different from pre-exercise within
the same treatment P < 0.05. #trend toward difference from pre-
exercise within the same treatment. †significantly different from
placebo condition within the same time point.
2014 | Vol. 2 | Iss. 8 | e12112
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time 9 group interaction; post hoc testing revealed that
p70S6K phosphorylation was significantly elevated above
fasting levels at 2 h post exercise only for groups receiv-
ing ≥20 g of whey protein supplementation. The fold
change from baseline in p70S6K Thr389 phosphorylation
was additionally significantly greater at 2 h post exercise
in response to 40 g whey intake when compared to either
the placebo or 10 g whey groups (P < 0.05). Further-
more, ingestion of 30 g of whey protein was found to
result in significantly greater p70S6K Thr389 phosphory-
lation when compared to the placebo condition only
(P < 0.05). Overall, linear regression analysis revealed a
significant dose-dependent relationship at 2 h post exer-
cise between whey protein dose ingested and the extent of
p70S6K Thr389 phosphorylation (r = 0.51, P < 001).
Intramuscular levels of leucine at 2 h post exercise were
found to be significantly and positively correlated with
the extent of p70S6K Thr389 phosphorylation (r = 0.32,
P = 0.026; Fig. 5) at 2 h of recovery. Similarly, this rela-
tionship was found to be significant for isoleucine
(P = 0.017, r = 0.33, data not shown), and exhibit a trend
toward significance for valine (P = 0.063, r = 0.27 data
not shown).
Discussion
This study shows that the dose–response relationship
between whey protein intake and p70S6K phosphorylation
in the muscle of older men during exercise recovery fol-
lows a similar pattern to that of the previously reported
between whey protein intake and MPS (Yang et al.
2012b). Furthermore, the present study is the first to
characterize the changes that occur in intramuscular
BCAA concentration following resistance exercise with or
without graded intakes of whey protein. The results show
that an acute bout of resistance exercise results in a
decrease in intramuscular BCAA concentration in older
men during postexercise recovery and that the whey pro-
tein supplementation can reverse this decline.
The reduction in intramuscular BCAA content after
resistance exercise observed in the present study may be
explained by three different, but not mutually exclusive,
fates: (1) utilization for protein synthesis; (2) conversion
to their respective branched-chain a-keto acids and subse-
quent release into the bloodstream; or (3) oxidization for
energy. (Shimomura et al. 2004; Brosnan and Brosnan
2006). In a murine model, high-resistance muscular con-
tractions performed in the fasted state have been shown
to promote an influx of BCAAs, especially leucine, into
the muscle (MacKenzie et al. 2009). Conversely, we found
that the resistance exercise performed by older men in
the fasted state in the absence of postexercise protein pro-
vision results in a decrease in intramuscular BCAA levels.
The lack of change observed in intramuscular 4-Methyl-
2-oxopentanoic acid (or a-ketoisocaproic acid, a-KIC)
might indicate that BCAAs were being used for protein
synthesis. However, it is also possible that BCAA metabo-
lites were released from the muscle or were oxidized
locally at a similar rate to which they were produced.
Indeed, at the whole body level, protein supplementation
has been shown to increase leucine oxidation during post-
exercise recovery (Yang et al. 2012b). Because we did not
measure a-KIC in other tissue pools or leucine oxidation
in the current study, we cannot make definitive claims
about the final metabolic fate of the elevated intramuscu-
lar BCAAs.
There has been a considerable interest into the optimal
dose of protein ingestion required to maximize muscle
anabolism during postexercise recovery (Moore et al.
2009; Yang et al. 2012b; Witard et al. 2014). We found
that as little as 10 g of whey protein was able to prevent
the significant decline in intramuscular BCAA levels dur-
ing postexercise recovery. However, only the larger doses
A
B
Figure 3. Intramuscular glutamic and aspartic acids. Fold changes
in (A) glutamic acid and (B) aspartic acid. *main effect for time,
significantly different from the pre-exercise fasted condition
P < 0.05.
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of whey (30 and 40 g) were able to increase BCAA levels
significantly above that seen in the placebo condition.
Wijekoon et al. (Wijekoon et al. 2004) have shown a
strong correlation among the concentrations of all three
BCAAs in plasma of rats. We extend this finding by
showing a similarly strong correlation between the levels
of the individual BCAAs in human muscle tissue, suggest-
ing that they share similar kinetics.
We found that whey protein supplementation also
increased the phosphorylation of p70S6k at Thr389 in a
dose-dependent manner. Although not statistically signifi-
cant, there was ~15% greater p70S6K phosphorylation
after the ingestion of 40 g of whey compared to 30 g sug-
gesting that a plateau may not have been reached. Addi-
tionally, the dose-dependent relationship beyond a 40 g
dose was supported by the overall significant linear rela-
tionship between p70S6K Thr389 phosphorylation and
whey dose ingested. The linear relationship between whey
protein dose and muscle p70S6K phosphorylation is in
agreement with the previously reported MPS data show-
ing an increasing anabolic response up to 40 g of whey
protein after resistance exercise in older men (Yang et al.
2012b). These data are in contrast to postexercise whey
supplementation data in young men showing an apparent
plateau in MPS response after the ingestion of whey
protein dose in surplus of 20 g (Witard et al. 2014).
Among the BCAAs, leucine is thought to be the
primary trigger of mTORC1 signaling (Drummond et al.
2009). Indeed, phosphorylation of p70S6k at Thr389 was
A
B
Figure 4. p70S6 kinase phosphorylation. Panel (A) shows representative western blots for p- p70S6K (Thr38), total p70S6K, and total ERK1
and 2 because of the large mobility shift in total p70S6K associated with phosphorylation total ERK2 was used as a loading control. Panel (B)
shows fold change in p70S6K phosphorylation from the pre-exercise fasted condition. *Significantly different from pre in the same condition
P < 0.05. **Significantly different from pre in the same condition P < 0.01. ***Significantly different from pre in the same condition P < 0.001
Within the 2 h post exercise condition treatments are significantly different from those with a different letter P < 0.05.
Figure 5. Relationship between p70S6 Kinase Phosphorylation and
Intramuscular Leucine. Fold change from rest of p70S6K
phosphorylation at 2 h post exercise was significantly correlated
with intramuscular leucine content at 2 h post exercise r = 0.32,
P = 0.026. The solid line represents the line of best fit as
determined by linear regression and the dotted lines represent 95%
confidence intervals.
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found to significantly correlate with intramuscular leucine
content in the present study. This correlation is in line
with mechanistic data showing that intracellular leucine
sensors are obligatory for mTOR pathway activation
(Zoncu et al. 2011; Han et al. 2012). Muscle protein syn-
thesis has previously been correlated to plasma leucine
concentration following protein ingestion in previous
studies (Pennings et al. 2011). To our knowledge, this is
the first study to report a correlation of p70S6K with
intramuscular leucine levels in humans. Interesting
however, p70S6K phosphorylation tended to be increased
during postexercise recovery in the placebo group, despite
a significant reduction in muscle leucine content, suggest-
ing that resistance exercise alone in the fasted state is
capable of stimulating this pathway through a leucine
independent mechanism (West and Baar 2013). Neverthe-
less, the replenishment of intramuscular leucine during
postexercise recovery appeared to promote an even
greater activation of mTORC1 pathway as evidenced by
heightened p70S6K phosphorylation. While p70S6K phos-
phorylation has been found to correlate with changes to
MPS in young adults, evidence suggests some disconnect
in the muscle of older subjects (Kumar et al. 2009; Fry
et al. 2011). Therefore, anabolic resistance within senes-
cent muscle may be related both to the ability of leucine
to activate p70S6K (Cuthbertson et al. 2005) as well as
disconnect between mTOR pathway activation and the
resulting MPS response. The impairment of MPS in the
muscle of elderly subjects in response to feeding and con-
traction has been controversial, with different studies
reporting opposing findings (Fry et al. 2011; Burd et al.
2013; Kiskini et al. 2013). This heterogeneity in study
findings may be due to a number of lifestyle factors such
as long-term diet and physical activity patterns which
may promote dissociation between chronological age and
anabolic sensitivity (Churchward-Venne et al. 2013a).
While the plasma amino acid response to protein feed-
ing, with or without resistance exercise, has been routinely
measured, intramuscular amino acid responses have
received much less attention. Bohe et al. (Bohe et al.
2003) concluded that at rest the infusion of amino acids
led to a large rise in plasma EAA content, but a decrease
in the levels of EAA locally within the skeletal muscle tis-
sue. These results were extrapolated to hypothesize that
extracellular, rather than intracellular EAA content, are the
primary regulators of the anabolic response to protein
feeding. Nevertheless, Bohe et al. measured only aggregate
EAA responses and did not report changes in individual
AAs or BCAAs (Bohe et al. 2003). This study also shows
greater intracellular EAA concentration compared with
plasma EAA levels suggesting that EAAs must travel up a
concentration gradient to enter the muscle cell. More
recent studies have replicated the finding of greater EAA
concentration intramuscularly compared to in circulation
but have found that BCAAs, and in particular leucine, are
found at higher concentrations in the plasma when com-
pared with the muscle sarcoplasm (Churchward-Venne
et al. 2012, 2014). Taken together, these results suggest
that BCAAs are regulated in a different manner than the
other EAAs. On this basis, it is important to consider the
concentration of the BCAA independent from other EAAs.
Previous studies have shown that in young and older
men, (Drummond et al. 2011) resistance exercise in the
fasted state reduces intramuscular leucine content. Fur-
thermore, in young men the provision of protein contain-
ing leucine after resistance exercise has been reported to
result in the maintenance of intramuscular leucine con-
tent during postexercise recovery (Churchward-Venne
et al. 2012, 2014). The present study expands on these
findings by showing that in older men the provision of
whey protein reverses the drop in intramuscular leucine
and other BCAAs caused by resistance exercise. Intramus-
cular leucine did not increase in a clear linear fashion
with increasing doses of whey protein, but did appear to
explain ~10% of the variance in p70S6K phosphorylation.
There are two likely explanations for the relatively low
proportion of the variance explained in p70S6K phos-
phorylation by intramuscular leucine levels. Firstly, recent
work suggests that the lumen of the lysosomes may be
the cellular location where amino acids (primarily
leucine) are sensed, so the direct measurement of this
subcellular concentration might yield a stronger correla-
tion with anabolic response (Zoncu et al. 2011). Secondly,
while aging results in an anabolic resistance to feeding, it
is likely that related decreases in physical activity and
increased inflammation mediate this anabolic resistance
rather than the chronological age per se (Churchward-
Venne et al. 2013b). This assertion is partially supported
by the relationship between intramuscular leucine and
p70S6K phosphorylation (Fig. 5) observed in the present
study, which appeared to show that some subjects (those
falling above the trend line) appear to possess a higher
anabolic sensitivity and are able to mount a larger
p70S6K phosphorylation response to smaller changes in
intramuscular leucine levels. On the other hand, there
was a subset of subjects (below the trend line) who exhib-
ited more modest augmentation of the p70S6K response
in the presence of a high intramuscular leucine levels.
Only very minor changes were observed in most of the
nonessential amino acids measured in human muscle in
the present study. However, both aspartic acid and
glutamic acid were found to be reduced intramuscularly
following resistance exercise, even following the ingestion
of the maximally tested 40 g dose of whey protein. This is
a somewhat surprising result given that glutamic acid and
aspartic acid are two of the most abundant amino acids in
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whey protein. The unresponsiveness of intramuscular
aspartic and glutamic acid to protein supplementation
may be explained by the fact that most of dietary aspartic
acid and glutamic acid are retained and utilized by the gas-
trointestinal tissues such that they may not be available to
the muscle in large amounts following feeding (Stoll and
Burrin 2006). Nevertheless, despite low intramuscular
aspartic acid and glutamic acid availability, subjects were
still able to mount a robust anabolic response as assessed
by p70S6K activation suggesting a disconnect between
these particular NEAAs and muscle anabolic signaling dur-
ing postexercise recovery.
Conclusion
This study shows that in older men resistance exercise in
the fasted state results in a decrease in intramuscular
BCAA content, but does not appear to influence the local
levels of the remaining EAAs. As little as 10 g of whey
protein supplementation was able to prevent the decrease
in intramuscular BCAAs that occurred when resistance
exercise was performed in the fasted state. While our
results suggest that larger doses 30–40 g of whey protein
were required to significantly increase intramuscular
BCAA levels above those seen with only placebo inges-
tion, p70S6K phosphorylation was increased in a dose-
dependent manner by ingestion of up to 40 g of whey
protein. This result is in agreement with recently reported
MPS data which show that in contrast to young men,
older subjects may require more than the 20 g of high-
quality protein in order to maximize the muscle anabolic
response during the postexercise recovery.
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